Similar phenomena can be also detected in prostate cancer cells, where RGS2 inhibits cell growth with the decreased RGS2 expression while RGS17 enhances cell growth with the increased RGS17 expression [72, 137, 138]. This evidence concerns the gene RGS17 and prostate cancer.